These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes. Celsi F; Crovella S; Moura RR; Schneider M; Vita F; Finotto L; Zabucchi G; Zacchi P; Borelli V J Toxicol Environ Health A; 2019; 82(20):1088-1102. PubMed ID: 31755376 [TBL] [Abstract][Full Text] [Related]
6. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years. Lin RT; Chang YY; Wang JD; Lee LJ J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers. Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620 [TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic features of erionite-induced malignant mesothelioma. Demirer E; Ghattas CF; Radwan MO; Elamin EM Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976 [TBL] [Abstract][Full Text] [Related]
9. The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region. Ke H; Kao S; Lee K; Takahashi K; Goh HP; Linton A Asia Pac J Clin Oncol; 2022 Jun; 18(3):177-190. PubMed ID: 34161674 [TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009. Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma. Laaksonen S; Kettunen E; Sutinen E; Ilonen I; Vehmas T; Törmäkangas T; Räsänen J; Wolff H; Myllärniemi M J Thorac Oncol; 2022 Aug; 17(8):1032-1041. PubMed ID: 35367351 [TBL] [Abstract][Full Text] [Related]
12. Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma. Digifico E; Erreni M; Mannarino L; Marchini S; Ummarino A; Anfray C; Bertola L; Recordati C; Pistillo D; Roncalli M; Bossi P; Zucali PA; D'Incalci M; Belgiovine C; Allavena P Front Immunol; 2023; 14():1116430. PubMed ID: 37398648 [TBL] [Abstract][Full Text] [Related]
13. ATG5 as biomarker for early detection of malignant mesothelioma. Tomasetti M; Monaco F; Strogovets O; Volpini L; Valentino M; Amati M; Neuzil J; Santarelli L BMC Res Notes; 2023 Apr; 16(1):61. PubMed ID: 37095543 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients. Kishimoto T; Fujimoto N; Ebara T; Omori T; Oguri T; Niimi A; Yokoyama T; Kato M; Usami I; Nishio M; Yoshikawa K; Tokuyama T; Tamura M; Yokoyama Y; Tsuboi K; Matsuo Y; Xu J; Takahashi S; Abdelgied M; Alexander WT; Alexander DB; Tsuda H BMC Cancer; 2019 Dec; 19(1):1204. PubMed ID: 31823764 [TBL] [Abstract][Full Text] [Related]
15. IL-7 is expressed in malignant mesothelioma and has a prognostic value. Mai HL; Deshayes S; Nguyen TV; Dehame V; Chéné AL; Brouard S; Blanquart C Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746 [TBL] [Abstract][Full Text] [Related]